Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2021. Start Trial.
Date Value
October 23, 2026 6.399
October 22, 2026 6.531
October 21, 2026 6.998
October 20, 2026 6.322
October 19, 2026 5.952
October 16, 2026 5.750
October 15, 2026 6.190
October 14, 2026 6.092
October 13, 2026 6.343
October 12, 2026 6.740
October 09, 2026 7.082
October 08, 2026 6.231
October 07, 2026 6.426
October 06, 2026 7.158
October 05, 2026 8.037
October 02, 2026 7.716
October 01, 2026 7.493
September 30, 2026 7.507
September 29, 2026 7.068
September 28, 2026 6.615
September 25, 2026 6.789
September 24, 2026 7.211
September 23, 2026 6.792
September 22, 2026 7.465
September 21, 2026 6.845
Date Value
September 18, 2026 6.726
September 17, 2026 6.461
September 16, 2026 5.604
September 15, 2026 5.534
September 14, 2026 5.639
September 11, 2026 5.722
September 10, 2026 5.743
September 09, 2026 6.029
September 08, 2026 6.210
September 04, 2026 6.148
September 03, 2026 6.134
September 02, 2026 6.134
September 01, 2026 6.162
August 31, 2026 6.301
August 28, 2026 6.071
August 27, 2026 6.566
August 26, 2026 6.426
August 25, 2026 6.712
August 24, 2026 6.162
August 21, 2026 6.656
August 20, 2026 6.468
August 19, 2026 6.963
August 18, 2026 6.169
August 17, 2026 6.440
August 14, 2026 6.399

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Twist Bioscience Corp. 19.67
Prime Medicine, Inc. 16.66
Moderna, Inc. 11.81
Tenax Therapeutics, Inc. 0.4838
Exicure, Inc. 6.850

Price to Book Value Related Metrics

PS Ratio 889.20
Price 9.18
Earnings Yield -8.72%
Market Cap 1.575B